Millennials and their Impact on Clinical Research
The importance of examining this generation’s influence on the clinical trial value chain.
Molasses in Study Startup Efficiencies
Numerous factors can adversely impact study startup and its efficiency, in an industry plagued by rising development costs and increasing complexities.
The Emergence of the Few: M&A in the CRO Industry
As the size, complexity, duration, cost, and globalization of clinical trials has grown, pharmaceutical and biotech companies have moved to outsource clinical activities to CROs to achieve a wide range of objectives.
Building Quality into Study Startup
With the availability of workflow-based study start-up tools, proactive planning is within reach for stakeholders who view this function as pivotal to improving clinical trial quality.
Eliminating the Three Evil "E's" in Starting Clinical Trials
Pharma has been transitioning from its paper based methods of the past toward automated cloud based systems in order to offset the cost of drug development. The emphasis is now shifting toward improved study startup processes for shorter clinical trial timelines.
Expediting Study Startup Across the Globe
The need for more efficient clinical trials is driving greater use of cloud-based solutions, especially with the rise in globalization
2 Clarke Drive Cranbury, NJ 08512